Analytical Project Manager

Yesterday

Apply Now

Receive Emails with Similar Jobs

Vaxcyte

WebsiteLinkedInAll Job Openings

51 - 200

Description

• Join our Mission to Protect Humankind! • Vaxcyte is a clinical-stage vaccine innovation company. • We engineer high-fidelity vaccines to protect humankind from bacterial diseases. • Our work together is guided by core values: Rethink Convention, Aim High, Lead with Heart, Model Excellence. • Project management to enable Analytical Development and Quality Control (AD/QC) organization. • Provide analytical leadership for clinical and commercial development of vaccine programs.

Requirements

• BA or BS degree in life sciences, engineering, or business administration; advanced degree desired. • PMP Certification and/or Project Management training desired. • Five to seven years of experience in the pharmaceutical or biotechnology industry with at least two years of relevant experience in an analytical organization, including significant experience in a cross-functional team environment. • Sound knowledge of analytical science, technical and regulatory expectations at all clinical phases including validation, analytical qualification, reference standard maintenance, and vaccine release testing. • Prior experience working in, or as a liaison with, contract testing organizations desired. • Expert analytical skills for integrating and interpreting interdisciplinary project information. • Strong planning and tracking skills, well-organized, focused on results, capable of managing multiple projects with respect to priorities and self-management. • Strong team management skills, including facilitation, conflict resolution, and team development. • Proven influence management and communication skills, at all levels of the organization. • Working knowledge of MS Word, Excel, PowerPoint, Visio, and Project. • Working knowledge of Veeva and Smartsheet a plus. • Excellent written and oral communication skills.

Benefits

• Competitive compensation package • Comprehensive benefits • Equity component